The company aims to disseminate scientific knowledge and promote research productivity through innovative technological solutions. This includes, among other things, the development and operation of platforms for all phases of the scientific process in the fields of immunology, biotechnology, and drug research. The company may engage in any business and take any measures suitable to promote the company's purpose directly or indirectly, such as acquiring, managing, using, encumbering, and disposing of real estate and intellectual property rights, both domestically and abroad, establishing branches and agencies, granting loans, managing capital, and providing guarantees in favor of affiliated companies. The company may grant direct or indirect financing to third parties or companies in which it is directly or indirectly involved, as well as to direct or indirect shareholders or companies in which they are directly or indirectly involved, either through loans and/or other financing, with or without compensation. The company may provide securities of any kind for its own obligations or the obligations of the aforementioned persons, including through pledges, assignments, fiduciary transfers, guarantees of any kind, or through compensation obligations, with or without compensation, even if such financing, securities, or guarantees are exclusively in the interest of third parties or companies in which it is directly or indirectly involved, or of direct or indirect shareholders or companies in which they are directly or indirectly involved.